Today’s article highlights six low-priced stocks that are in uptrends – and which analysts believe could double in value. Specifically, each of these six stocks is priced at less than $5 a share, is trading at least 50% below analysts’ target price for the stock, and is trading above its 200 day moving average. For these six cheap stocks with the potential to double – including a clinical-stage biopharmaceutical company and a stock offering exposure to Brazil’s economic turnaround – CLICK HERE.
These Six Stocks Are Under $5 – And At Least 50% Below Their Target Price
Tags:$5 SharesAnalystBiopharmaceutical Stockscheap stocksInvestInvestmentInvestorLow PricesLow-Priced StocksMarket Analyststock marketStock PriceTarget Stock PricesUptrend Stocks